.png)
Molecular Diagnostic Instrument Market by Type and Application- Global Industry Analysis & Forecast to 2027
Published On : January 2021 Pages : 152 Category: Medical Devices Report Code : HC0114876
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Molecular Diagnostic Instrument Market by Type(PCR Instrument,Nucleic Acid Extractor,Genetic Sequencer,Gene Chip Instrument,Nucleic Acid Molecule Hybridization Instrument)Application (Laboratory,Clinic, Hospital)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
Molecular Diagnostic Instrument Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Molecular diagnostic advances have enabled the identification of various diseases and are especially productive in the face of difficult differential diagnosis. As they promote cost-effectiveness, precision, and portability, technological developments in molecular diagnostics are expected to significantly drive market development.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- ThermoFisher
- Illumina
- Macrogen
- DAAN Gene
- Roche
- BGI Group
- QIAGEN
- Agilent Technologies
- ELITech Group
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Molecular Diagnostic Instrument Market, ByType, Estimates and Forecast, 2017-2027 ($Million)
o PCR Instrument
o Nucleic Acid Extractor
o Genetic Sequencer
o Gene Chip Instrument
o Nucleic Acid Molecule Hybridization Instrument
· Molecular Diagnostic Instrument Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Laboratory
o Clinic
· Molecular Diagnostic Instrument Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o ThermoFisher
o Illumina
o Macrogen
o DAAN Gene
o Roche
o BGI Group
o QIAGEN
o Agilent Technologies
o ELITech Group
· Molecular Diagnostic Instrument Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Molecular Diagnostic Instrument Market, By Country
o U.S. Molecular Diagnostic Instrument Market
o Canada Molecular Diagnostic Instrument Market
o Mexico Molecular Diagnostic Instrument Market
o Europe
§ Europe Molecular Diagnostic Instrument Market, By Country
· Germany Molecular Diagnostic Instrument Market
o UK Molecular Diagnostic Instrument Market
o France Molecular Diagnostic Instrument Market
o RussiaMolecular Diagnostic Instrument Market
o Italy Molecular Diagnostic Instrument Market
o Rest of Europe Molecular Diagnostic Instrument Market
o Asia-Pacific
§ Asia-Pacific Molecular Diagnostic Instrument Market, By Country
o ChinaMolecular Diagnostic Instrument Market
o Japan Molecular Diagnostic Instrument Market
o South KoreaMolecular Diagnostic Instrument Market
o India Molecular Diagnostic Instrument Market
o Southeast AsiaMolecular Diagnostic Instrument Market
o Rest of Asia-Pacific Molecular Diagnostic Instrument Market
o South America
§ South AmericaMolecular Diagnostic Instrument Market
o Brazil Molecular Diagnostic Instrument Market
o ArgentinaMolecular Diagnostic Instrument Market
o ColumbiaMolecular Diagnostic Instrument Market
o Rest of South America Molecular Diagnostic Instrument Market
o Middle East and Africa
§ Middle East and AfricaMolecular Diagnostic Instrument Market
o Saudi ArabiaMolecular Diagnostic Instrument Market
o UAEMolecular Diagnostic Instrument Market
o EgyptMolecular Diagnostic Instrument Market
o NigeriaMolecular Diagnostic Instrument Market
o South Africa Molecular Diagnostic Instrument Market
o Rest of MEA Molecular Diagnostic Instrument Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Molecular Diagnostic Instrument Market, By Type
5.1. Introduction
5.2. Global Molecular Diagnostic Instrument Revenue and Market Share by Type (2017-2021)
5.2.1. Global Molecular Diagnostic Instrument Revenue and Revenue Share by Type (2017-2021)
5.3. PCR Instrument
5.3.1. Global PCR Instrument Revenue and Growth Rate (2017-2021)
5.4. Nucleic Acid Extractor
5.4.1. Global Nucleic Acid Extractor Revenue and Growth Rate (2017-2021)
5.5. Genetic Sequencer
5.5.1. Global Genetic Sequencer Revenue and Growth Rate (2017-2021)
5.6. Gene Chip Instrument
5.6.1. Global Gene Chip Instrument Revenue and Growth Rate (2017-2021)
5.7. Nucleic Acid Molecule Hybridization Instrument
5.7.1. Global Nucleic Acid Molecule Hybridization Instrument Revenue and Growth Rate (2017-2021)
6. Molecular Diagnostic Instrument Market, By Application
6.1. Introduction
6.2. Global Molecular Diagnostic Instrument Revenue and Market Share by Application (2017-2021)
6.2.1. Global Molecular Diagnostic Instrument Revenue and Revenue Share by Application (2017-2021)
6.3. Laboratory
6.3.1. Global Laboratory Revenue and Growth Rate (2017-2021)
6.4. Hospital
6.4.1. Global Hospital Revenue and Growth Rate (2017-2021)
6.5. Clinic
6.5.1. Global Clinic Revenue and Growth Rate (2017-2021)
7. Molecular Diagnostic Instrument Market, By Region
7.1. Introduction
7.2. Global Molecular Diagnostic Instrument Revenue and Market Share by Regions
7.2.1. Global Molecular Diagnostic Instrument Revenue by Regions (2017-2021)
7.3. North America Molecular Diagnostic Instrument by Countries
7.3.1. North America Molecular Diagnostic Instrument Revenue and Growth Rate (2017-2021)
7.3.2. North America Molecular Diagnostic Instrument Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Molecular Diagnostic Instrument by Countries
7.4.1. Europe Molecular Diagnostic Instrument Revenue and Growth Rate (2017-2021)
7.4.2. Europe Molecular Diagnostic Instrument Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Molecular Diagnostic Instrument by Countries
7.5.1. Asia-Pacific Molecular Diagnostic Instrument Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Molecular Diagnostic Instrument Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Molecular Diagnostic Instrument by Countries
7.6.1. South America Molecular Diagnostic Instrument Revenue and Growth Rate (2017-2021)
7.6.2. South America Molecular Diagnostic Instrument Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Molecular Diagnostic Instrument by Countries
7.7.1. Middle East and Africa Molecular Diagnostic Instrument Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Molecular Diagnostic Instrument Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. ThermoFisher
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Illumina
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Macrogen
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. DAAN Gene
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Roche
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. BGI Group
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. QIAGEN
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Agilent Technologies
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. ELITech Group
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
9. Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.1. Global Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Molecular Diagnostic Instrument Market Forecast by Regions (2022-2027)
9.2.1. North America Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.1.1. United States Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.1.2. Canada Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.1.3. Mexico Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.2. Europe Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.2.1. Germany Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.2.2. France Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.2.3. UK Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.2.4. Russia Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.2.5. Italy Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.3. Asia-Pacific Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.3.1. China Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.3.2. Japan Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.3.3. Korea Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.3.4. India Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.4. South America Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.4.1. Brazil Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.4.2. Argentina Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.4.3. Columbia Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.4.4. Rest of South America Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.5. Middle East and Africa Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.5.3. Egypt Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.5.4. Nigeria Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.5.5. South Africa Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.5.6. Turkey Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Molecular Diagnostic Instrument Market Forecast (2022-2027)
9.3. Molecular Diagnostic Instrument Market Forecast by Type (2022-2027)
9.3.1. Molecular Diagnostic Instrument Forecast by Type (2022-2027)
9.3.2. Molecular Diagnostic Instrument Market Share Forecast by Type (2022-2027)
9.4. Molecular Diagnostic Instrument Market Forecast by Application (2022-2027)
9.4.1. Molecular Diagnostic Instrument Forecast by Application (2022-2027)
9.4.2. Molecular Diagnostic Instrument Market Share Forecast by Application (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Molecular Diagnostic Instrument Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Molecular Diagnostic Instrument Revenue and Revenue Share by Type (2017-2019)
Figure Global PCR Instrument Revenue and Growth Rate (2017-2019)
Figure Global Nucleic Acid Extractor Revenue and Growth Rate (2017-2019)
Figure Global Genetic Sequencer Revenue and Growth Rate (2017-2019)
Figure Global Gene Chip Instrument Revenue and Growth Rate (2017-2019)
Figure Global Nucleic Acid Molecule Hybridization Instrument Revenue and Growth Rate (2017-2019)
Table Global Molecular Diagnostic Instrument Revenue and Revenue Share by Application (2017-2019)
Figure Global Laboratory Revenue and Growth Rate (2017-2019)
Figure Global Hospital Revenue and Growth Rate (2017-2019)
Figure Global Clinic Revenue and Growth Rate (2017-2019)
Table Global Molecular Diagnostic Instrument Revenue by Regions (2017-2019)
Figure North America Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure North America Molecular Diagnostic Instrument Revenue and Growth Rate (2017-2019)
Figure North America Molecular Diagnostic Instrument by Countries (2017-2019)
Figure North America Molecular Diagnostic Instrument Revenue (Million USD) by Countries (2017-2019)
Figure United States Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure United States Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure Canada Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure Mexico Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure Europe Molecular Diagnostic Instrument Revenue and Growth Rate (2017-2019)
Figure Europe Molecular Diagnostic Instrument by Countries (2017-2019)
Figure Europe Molecular Diagnostic Instrument Revenue (Million USD) by Countries (2017-2019)
Figure Germany Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure Germany Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure France Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure UK Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure Russia Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure Italy Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure Rest of Europe Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure Asia-Pacific Molecular Diagnostic Instrument Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Molecular Diagnostic Instrument by Countries (2017-2019)
Figure Asia-Pacific Molecular Diagnostic Instrument Revenue (Million USD) by Countries (2017-2019)
Figure China Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure China Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure Japan Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure Korea Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure India Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure Southeast Asia Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure South America Molecular Diagnostic Instrument Revenue and Growth Rate (2017-2019)
Figure South America Molecular Diagnostic Instrument by Countries (2017-2019)
Figure South America Molecular Diagnostic Instrument Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure Brazil Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure Argentina Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure Columbia Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure Rest of South America Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure Middle East and Africa Molecular Diagnostic Instrument Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Molecular Diagnostic Instrument by Countries (2017-2019)
Figure Middle East and Africa Molecular Diagnostic Instrument Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure Saudi Arabia Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure United Arab Emirates Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure Egypt Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure Nigeria Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure South Africa Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure Turkey Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Molecular Diagnostic Instrument Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2017-2019)
Table ThermoFisher Molecular Diagnostic Instrument Financial Overview
Table Illumina Molecular Diagnostic Instrument Financial Overview
Table Macrogen Molecular Diagnostic Instrument Financial Overview
Table DAAN Gene Molecular Diagnostic Instrument Financial Overview
Table Roche Molecular Diagnostic Instrument Financial Overview
Table BGI Group Molecular Diagnostic Instrument Financial Overview
Table QIAGEN Molecular Diagnostic Instrument Financial Overview
Table Agilent Technologies Molecular Diagnostic Instrument Financial Overview
Table ELITech Group Molecular Diagnostic Instrument Financial Overview
Figure Global Molecular Diagnostic Instrument Revenue (Millions USD) and Growth Rate (2019-2027)
Table Molecular Diagnostic Instrument Market Forecast by Regions (2019-2027)
Figure North America Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure United States Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure Canada Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure Mexico Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure Europe Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure Germany Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure France Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure UK Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure Russia Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure Italy Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure Rest of Europe Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure Asia-Pacific Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure China Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure Japan Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure Korea Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure India Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure Southeast Asia Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure South America Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure Brazil Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure Argentina Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure Columbia Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure Rest of South America Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure Middle East and Africa Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure Saudi Arabia Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure United Arab Emirates Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure Egypt Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure Nigeria Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure South Africa Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure Turkey Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Molecular Diagnostic Instrument Market Forecast (2019-2027)
Figure Global Molecular Diagnostic Instrument Forecast by Type (2019-2027)
Figure Global Molecular Diagnostic Instrument Market Share Forecast by Type (2019-2027)
Figure Global Molecular Diagnostic Instrument Forecast by Type (2019-2027)
Figure Global Molecular Diagnostic Instrument Forecast by Application (2019-2027)
Figure Global Molecular Diagnostic Instrument Market Share Forecast by Application (2019-2027)
Figure Global Molecular Diagnostic Instrument Forecast by Application (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|